The drugstore chain made a blood-testing deal without fully validating the startup’s technology, worrying that Elizabeth Holmes might balk if Walgreens pushed too hard.
WSJ.com: US Business, Wall Street Journal: Business
Wed, 05/25/2016 - 1:38pm
The drugstore chain made a blood-testing deal without fully validating the startup’s technology, worrying that Elizabeth Holmes might balk if Walgreens pushed too hard.